efficacy of bispecific cd19/cd22 car t-cells in b-cell malignancies
Published 2 years ago • 972 plays • Length 2:37Download video MP4
Download video MP3
Similar videos
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
2:32
phase i study of cd22-targeted car-t therapy in patients with cd19-negative b-all
-
3:23
second cd19-targeted car t-cell infusion for r/r b-cell malignancies
-
1:39
out of specification anti-cd19 car t-cell products in aggressive b-cell lymphomas
-
7:29
tutorial multifiltrate pro cvvhd ci-ca [ english ]
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
1:05
minicollect® capillary blood collection tube - improved cap design
-
4:47
cd19 car t-cells for adults
-
3:34
humanized versus murinized cd19/cd22 car-t cell therapy for r/r b-cell lymphoma
-
6:02
car-t vs. bites in b-cell malignancies
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
1:59
efficacy and safety of cd19-targeted car t-cells for relapsed/refractory all
-
1:51
current research on cd19 targeted car t-cells in relapsed b-cell all
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
2:01
advances in cd22/cd19 car-t sequential therapy
-
4:45
safety and efficacy of obe-cel in r/r adult b-all: results of the pivotal felix study
-
4:24
key questions in the field of cd19 car t-cell therapy
-
1:35
key mechanisms of resistance to car t-cell therapy
-
1:38
exploring novel humanized anti-cd19 car-t cells as a strategy to minimize crs and other toxicities
-
2:55
cd19 car t-cell therapy for lymphoma
-
4:10
the challenges of car t-cell therapy for pediatric b-all
-
1:42
novel treatment combinations in aml: what’s to come?